Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro
Liu Y, Wang D, Zhang D, Lv Y, Wei Y, Wu W, Zhou F, Tang M, Mao T, Li M, Ji B
Journal of agricultural and food chemistry · 60 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- In vitro/mechanistic study (classified by our AI screen)
- Studied in
- Cells or lab samples
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2011-10-15 · J Agric Food Chem · vol. 59 · issue 22 · pp. 12254–12263
- Publisher
- American Chemical Society
- Cited
- 87 citations · more than 93% of similar papers · 3.9× the field average
- Impact
- Top 10% most cited in its field
- References
- 45 works
- Access
- Paywalled
- Research areas
- Liver Disease Diagnosis and Treatment · Diet, Metabolism, and Disease · Phytochemicals and Antioxidant Activities
- Keywords
- Caffeic acid, Steatosis, Chemistry, Polyphenol, Nonalcoholic fatty liver disease, Chlorogenic acid, Fatty liver, Oleic acid, Triglyceride, Insulin resistance, Biochemistry, Food science, Internal medicine, Insulin, Antioxidant, Medicine, Cholesterol
- MeSH
- humans, fatty liver, oleic acid, triglycerides, plant extracts, protective agents, models, biological, hep g2 cells, polyphenols, non-alcoholic fatty liver disease, blueberry plants
11 authors
From CN
- Yixiang LiuChina Agricultural University
- Dan WangChina Agricultural University
- Di ZhangChina Agricultural University
- Yechun LvChina Agricultural University
- Ying WeiChina Agricultural University
- Wei WuChina Agricultural University
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and is closely associated with metabolic syndromes, such as obesity, diabetes, and insulin resistance. Nonalcoholic fatty liver (NAFL), also called simple steatosis, is the initial phase of NAFLD, which is accompanied the characteristic pathological overaccumulation of lipids without inflammation. To prevent NAFLD from reaching the NAFL stage through dietary therapy, in the present work, wild Chinese blueberries (Vacciniun spp.) were selected for their well-known benefits in inhibiting metabolic syndrome. After being purified from wild Chinese blueberries, polyphenol-rich extracts were subsequently separated into three fractions, namely, anthocyanin-rich fraction, phenolic acid-rich fraction, and ethyl acetate extract. The inhibition of oleic acid (OA)-induced triglyceride (TG) deposition in HepG 2 cells was referred to as the potential activity of preventing NAFL. Biochemical indicators, such as cytotoxicity, TG level, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and intracellular reactive oxygen species, were used to evaluate the analogous pathological stage of NAFLD. The results show that OA ≤ 1.0 mM exhibits a dose-dependent induction of TG accumulation, and no inflammation was observed based on the changes in ALT and AST levels. Therefore, 1.0 mM OA was used to simulate an in vitro fatty liver. Blueberry polyphenol-rich extract efficiently inhibited OA-induced TG accumulation in HepG2 cells, and the phenolic acid-rich fraction performed efficiently. Seven phenolic acids were subsequently identified using a high-performance liquid chromatography assay, and the main types were caffeic, chlorogenic, ferulic, p-coumaric, and cinnamic acids. These phenolic acid standards also displayed good efficiency in inhibiting TG accumulation in HepG2 cells. These results imply that wild Chinese blueberries have a potential preventive effect on NAFLD in its early stage, and phenolic acids are the most efficient component.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.